Meng Wu
- Oncology top 5%
- Molecular Biology
- Immunology top 5%
- Biomedical Engineering
- Pulmonary and Respiratory Medicine
- Co-authors
- Hugues J.‐P. RyserF GhaniDerek PeakRichard MandelJinming YuDawei ChenXiaochuan HongLiufu Deng
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)Immunotherapy and Immune Responses (6 papers)CAR-T cell therapy research (5 papers)
- Cited by
- ImmunologyOncologyMolecular Biology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Meng Wu
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 78
- Oncology 513
- Molecular Biology 485
- Immunology 463
- Biomedical Engineering 190
- Pulmonary and Respiratory Medicine 143
Countries citing papers authored by Meng Wu
This map shows the geographic impact of Meng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Wu more than expected).
Fields of papers citing papers by Meng Wu
This network shows the impact of papers produced by Meng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Wu. The network helps show where Meng Wu may publish in the future.
Co-authorship network of co-authors of Meng Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Meng Wu. A scholar is included among the top collaborators of Meng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Wu. Meng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 7 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 21 | |
| 7 | 1 | |
| 8 | 26 | |
| 9 | 2 | |
| 10 | 7 | |
| 11 | 11 | |
| 12 | 8 | |
| 13 | 30 | |
| 14 | 5 | |
| 15 | 6 | |
| 16 | 52 | |
| 17 | 2 | |
| 18 | 3 | |
| 19 | 17 | |
| 20 | 299 |
About Meng Wu
Meng Wu is a scholar working on Oncology, Immunology and Toxicology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Immunology (463 citations), Oncology (513 citations) and Molecular Biology (485 citations). Meng Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hugues J.‐P. Ryser, F Ghani, Derek Peak, Richard Mandel, Jinming Yu, Dawei Chen, Xiaochuan Hong, Liufu Deng, Jingsi Jin and Yuanqin Yang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.